Runze Shang

Therapeutic efficacy of FASN inhibition in preclinical models of HCC

Haichuan Wang, Yi Zhou, Hongwei Xu et al. · Hepatology · 2022 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

Cabozantinib-based combination therapy for the treatment of hepatocellular carcinoma

Runze Shang, Xinhua Song, Pan Wang et al. · Gut · 2020 · 107 citations · Full text

Medicine, Oncology, Pharmacology +17

The mTORC2‐Akt1 Cascade Is Crucial for c‐Myc to Promote Hepatocarcinogenesis in Mice and Humans

Zhong Xu, Meng Xu, Liu Pin et al. · Hepatology · 2019 · 100 citations · Full text

Medicine, Cell Biology, Oncology +15

Long noncoding RNA <i>SLC2A1‐AS1</i> regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway

Runze Shang, Miao Wang, Bin Dai et al. · Molecular Oncology · 2020 · 98 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

RETRACTED ARTICLE: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612

Xisheng Yang, Shibin Qu, Lin Wang et al. · Oncogene · 2018 · 89 citations

Life Sciences, Cancer Biology, Genetics +14